Direct-To-Consumer drug advertising: You get what you pay for

Health Affairs

Volumn 23, Issue SUPPL., 2004, Pages

  Jeffords, James M ^a,b  

^a United States Senate ^*

^b Hlth Educ Labor Pensions Comm

Author keywords

[No Author keywords available]

Indexed keywords

ADVERTIZING; CONSUMER; DOCTOR PATIENT RELATION; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MARKETING; GOVERNMENT; HEALTH CARE POLICY; HEALTH CARE QUALITY; SHORT SURVEY;

EID: 4644366553     PISSN: 02782715     EISSN: None     Source Type: Journal    
DOI: 10.1377/hlthaff.W4.253     Document Type: Short Survey

References (8)

1. J.S. Weissman et al., "Physicians Report on Patient Encounters Involving Direct-to-Consumer Advertising," Health Affairs, 28 April 2004, content.healthaffairs.org/cgi/content/abstract/hlthaff.w4.219 (28 April 2004); and S. Woloshin et al., "The Value of Benefit Data in Direct-to-Consumer Drug Ads," Health Affairs, 28 April 2004, content.healthaffairs.org/cgi/ content/abstract/hlthaff.w4.234 (28 April 2004).
2. J.S. Weissman et al., "Physicians Report on Patient Encounters Involving Direct-to-Consumer Advertising," Health Affairs, 28 April 2004, content.healthaffairs.org/cgi/content/abstract/hlthaff.w4.219 (28 April 2004); and S. Woloshin et al., "The Value of Benefit Data in Direct-to-Consumer Drug Ads," Health Affairs, 28 April 2004, content.healthaffairs.org/cgi/ content/abstract/hlthaff.w4.234 (28 April 2004).
3. U.S. General Accounting Office, Prescription Drugs: FDA Oversight of Direct to Consumer Advertising Has Limitations, Pub. no. GAO-03-177 (Washington: GAO, October 2002).
4. D.U. Vogt, "Direct-to-Consumer Advertising of Prescription Drugs," CRS Report for Congress, RL31603 (Washington: Congressional Research Service, 10 October 2002).
5. Ibid., 2-7.
6. Ibid., 2-7.
7. GAO, Prescription Drugs.
8. Ibid., 4